Dora Delsordo, APN, C | |
195 Little Albany St, Cancer Institute Of Nj - Pediatric Heme/onc, New Brunswick, NJ 08901-1914 | |
(732) 235-8498 | |
(732) 235-6462 |
Full Name | Dora Delsordo |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Pediatrics |
Location | 195 Little Albany St, New Brunswick, New Jersey |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487739371 | NPI | - | NPPES |
7829001 | Medicaid | NJ |
Entity Name | Rutgers Health-rwj Pediatric Hematology-oncology |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104842285 PECOS PAC ID: 2163334509 Enrollment ID: O20031104000142 |
News Archive
At present, a focus on males in basic research and clinical trials means that models of disease are also based on men. Symptoms and disease progression in male patients are therefore considered the standard, while disease manifestations that are usually observed in women are judged "atypical".
Boston Scientific Corporation (NYSE: BSX) today welcomed three-year results from the SPIRIT III clinical trial, which continue to reaffirm the proven long-term safety of the Company's portfolio of drug-eluting stents, including the first-generation TAXUS((R)) Express(2)(TM) Paclitaxel-Eluting Coronary Stent System and the XIENCE V(TM) (PROMUS((R))) Everolimus-Eluting Coronary Stent System.
Scott & White Healthcare researchers are studying an investigational agent that targets metastatic breast cancer to find if it can stop cancer cells from continuing to grow.
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office.
› Verified 3 days ago
Entity Name | Rutgers Health-rwj Scleroderma Program |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679655781 PECOS PAC ID: 5193764991 Enrollment ID: O20050502000326 |
News Archive
At present, a focus on males in basic research and clinical trials means that models of disease are also based on men. Symptoms and disease progression in male patients are therefore considered the standard, while disease manifestations that are usually observed in women are judged "atypical".
Boston Scientific Corporation (NYSE: BSX) today welcomed three-year results from the SPIRIT III clinical trial, which continue to reaffirm the proven long-term safety of the Company's portfolio of drug-eluting stents, including the first-generation TAXUS((R)) Express(2)(TM) Paclitaxel-Eluting Coronary Stent System and the XIENCE V(TM) (PROMUS((R))) Everolimus-Eluting Coronary Stent System.
Scott & White Healthcare researchers are studying an investigational agent that targets metastatic breast cancer to find if it can stop cancer cells from continuing to grow.
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dora Delsordo, APN, C 34 White Meadow Rd, Hillsborough, NJ 08844-1600 Ph: (908) 371-1152 | Dora Delsordo, APN, C 195 Little Albany St, Cancer Institute Of Nj - Pediatric Heme/onc, New Brunswick, NJ 08901-1914 Ph: (732) 235-8498 |
News Archive
At present, a focus on males in basic research and clinical trials means that models of disease are also based on men. Symptoms and disease progression in male patients are therefore considered the standard, while disease manifestations that are usually observed in women are judged "atypical".
Boston Scientific Corporation (NYSE: BSX) today welcomed three-year results from the SPIRIT III clinical trial, which continue to reaffirm the proven long-term safety of the Company's portfolio of drug-eluting stents, including the first-generation TAXUS((R)) Express(2)(TM) Paclitaxel-Eluting Coronary Stent System and the XIENCE V(TM) (PROMUS((R))) Everolimus-Eluting Coronary Stent System.
Scott & White Healthcare researchers are studying an investigational agent that targets metastatic breast cancer to find if it can stop cancer cells from continuing to grow.
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office.
› Verified 3 days ago
Mrs. Courtney Elizabeth Resciniti, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 125 Paterson St Ste 3300, New Brunswick, NJ 08901 Phone: 732-235-7821 Fax: 732-235-8878 | |
Lauren Horton, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 200 Somerset St, New Brunswick, NJ 08901 Phone: 888-244-5373 | |
Devon Amanda Orzano, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl, 2 Core - Rm. 257, New Brunswick, NJ 08901 Phone: 732-828-3000 | |
Sherene Tanasha Dunkley, APN-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 254 Easton Ave, New Brunswick, NJ 08901 Phone: 732-745-8600 | |
Andrew Thomas, MSN, APN-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 Phone: 732-828-3000 | |
Daniela Manole Raabe, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 200 Somerset St, New Brunswick, NJ 08901 Phone: 646-226-2137 | |
Ms. Kathy O Covert, APN-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 254 Easton Ave, New Brunswick, NJ 08901 Phone: 732-745-8600 |